Moleculin Biotech Inc (MBRX)
2.36
-0.10
(-4.06%)
USD |
NASDAQ |
Oct 04, 16:00
2.33
-0.03
(-1.27%)
After-Hours: 20:00
Moleculin Biotech Shareholders Equity (Annual): 26.07M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.07M |
| December 31, 2022 | 52.19M |
| December 31, 2021 | 78.99M |
| December 31, 2020 | 17.76M |
| December 31, 2019 | 15.57M |
| Date | Value |
|---|---|
| December 31, 2018 | 14.27M |
| December 31, 2017 | 17.12M |
| December 31, 2016 | 14.96M |
| December 31, 2015 | -0.7447M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
15.57M
Minimum
2019
78.99M
Maximum
2021
38.12M
Average
26.07M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Agilent Technologies Inc | 5.845B |
| Seelos Therapeutics Inc | -33.51M |
| Cara Therapeutics Inc | 57.08M |
| Citius Pharmaceuticals Inc | 90.83M |
| NovaBay Pharmaceuticals Inc | 3.314M |